Bank of New York Mellon Corp Sells 8,512 Shares of ASP Isotopes Inc. (NASDAQ:ASPI)

Bank of New York Mellon Corp lowered its stake in shares of ASP Isotopes Inc. (NASDAQ:ASPI) by 6.3% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 125,874 shares of the company’s stock after selling 8,512 shares during the quarter. Bank of New York Mellon Corp owned approximately 0.18% of ASP Isotopes worth $570,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Barclays PLC grew its position in shares of ASP Isotopes by 438.5% during the 3rd quarter. Barclays PLC now owns 72,330 shares of the company’s stock valued at $201,000 after acquiring an additional 58,897 shares during the period. Geode Capital Management LLC grew its holdings in ASP Isotopes by 42.7% during the third quarter. Geode Capital Management LLC now owns 1,118,423 shares of the company’s stock valued at $3,110,000 after purchasing an additional 334,836 shares during the period. Walleye Capital LLC purchased a new stake in ASP Isotopes in the third quarter worth $536,000. Jane Street Group LLC raised its stake in shares of ASP Isotopes by 31.7% in the third quarter. Jane Street Group LLC now owns 145,969 shares of the company’s stock valued at $406,000 after buying an additional 35,166 shares during the period. Finally, State Street Corp lifted its position in shares of ASP Isotopes by 12.8% during the 3rd quarter. State Street Corp now owns 853,695 shares of the company’s stock valued at $2,373,000 after buying an additional 96,604 shares during the last quarter. Hedge funds and other institutional investors own 16.80% of the company’s stock.

ASP Isotopes Trading Up 12.9 %

Shares of ASPI opened at $4.73 on Friday. ASP Isotopes Inc. has a fifty-two week low of $1.86 and a fifty-two week high of $9.33. The business has a 50-day moving average of $5.04 and a 200 day moving average of $4.89. The firm has a market cap of $337.67 million, a P/E ratio of -7.75 and a beta of 3.66. The company has a debt-to-equity ratio of 0.80, a quick ratio of 7.54 and a current ratio of 7.55.

ASP Isotopes Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.